Skip to content

Clinical trials

Obesity, Abdominal trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity, Abdominal Country / region: China Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20141
20161
20171
20191
20202
20211
20221
20233
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Unknown status3
Recruiting2
Active, not recruiting1
Enrolling by invitation1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
China National Center for Cardiovascular Diseases2
Dongfang Hospital Beijing University of Chinese Medicine2
Third Military Medical University2
Beijing Sport University1
Chinese University of Hong Kong1
Daorong Wang1
Eli Lilly and Company1
Guang'anmen Hospital of China Academy of Chinese Medical Sciences1
Hubei Hospital of Traditional Chinese Medicine1
RenJi Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity, Abdominal18
Obesity6
Hypertension3
Metabolic Syndrome3
Prediabetic State3
Dyslipidemias2
Non-alcoholic Fatty Liver Disease2
Atherosclerosis1
Breast Neoplasms1
Diabetes Mellitus1

Trials

Showing 26 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.